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Heart rate andaorticPressurewereassessedat eachpoint.Phe induced
a similar increase of the rate-pressure produdt: 32 + 24Y0,35 + 27?L0,and
35 k 30%, respectively, in Groups 1, 2 and in C (all p <0.001 vs base).
Concomitant increase in corona~ blood flow velocity was observed: 28 A
19%, 28& 22%, and 29 + 20Y0,respectively, in the 3 Groups (all p <0.001
vs beae). The systemic effects of Phe disappeared between 5 to 7 min after
infusion. Results regarding vasomotor responses are shown in the figure: *p
<0.001 vs base, # p c 0.05 and 9 p <0.001 between groups.
Conclusion: In HTX with angiographicelly normal corona~ arteries, the
syatemiceffectsof Phe induce an early flow-dependent endothelium-msdiated
vasodilation, that turns lately into vasoconstriction.
Graft atherosclerosis abolishes the endothelium-mediated vasodilation
caused by Phe, which induces an a-receptor-mediated constricting effect
that is precocious and sustained.
m953153 Potential for Improved Aaeeasment of TransplantGraft Vascular Disease Extent and Progression
Ueing Instantaneous 3D Intracoronary Ultrasound
Imaging
J.A. White, P.W.Pflugfelder, D.R. Boughner, J. Dietrich, A. Chae,
W.J. Kostuk. University Hospital and Robarts Reaearch Institute, London,
Canada
Serial analysis of intracoronary ultrasound (ICUS) images is limited by diffi-
cultywith spatial registration and inability to assess the full burden of vasculer
disease. Three dimensional (3D) imaging of coronary erteries can potentially
overcome these deficiencies. In this study, the feasibility of using a unique, in-
stantaneous, Macintosh PC baaed 3D rendering technique was assessed.To
define theaccuracyof 3D ICUS measurements in vitro, 4 porcine iliacvessels
(3.8 to6.4 mm diameter) were pressure-fixed and imaged with a commercial
CVIS ultrasound system. Using a motorized continuous pull-beck device,
a 3.2 Fr catheter operating at 30 MHz was withdrawn through the vessel.
Using unique software, 3D datasets of the vessels wereconstructed. Artery
specimens were then mounted and serially sectioned by sledge microtome
for dimensional anaiysis. Measurements from 3D US datasets were corre-
Iated with histological measurements. For Iuminal area data in all 4 vessels,
the correlation coefficient was 0.96 (p < 0.0001), while for Iuminal volume
measurements a correlation coefficient of 1.0 (p < 0.0001) was observed.
Length comparisons yielded acorrelafion coefficient of 0.99 (p< 0.005) in the
vessels and also subsequently a correlation coefficient of 1.0 (p < 0.0003)
in 4 Iucite vessel phantoms. In 18 heart transplant recipients, 53 in vivo 3D
image volumes of 20 to 50 mm length were obtained from 1or more coronav
arteries. In 183D image volumes, the longitudinal and circumferential extent
of intimal hyperplaeia or localized calcific plaque was clearly seen. This 3D
ICUS technique allowe rapid and accurate measurement of vessel length
and volume in addition to Iuminal area values, and can demonstrate the
full extent of atherosclerotic pathology. It has the potential to provide accu-
rate aerial assessment in atudies of pharmacologic intervention in transplant
arteriopathy.
m953154 Correlation of Clinical Factors and Epicardial
Vaacular Morphology With Coronary Flow
Reaerve in Heart Transplant Recipients as
Asaeseed by Intracoronary Doppler
V. Klauss, K.IH. Henneke, C.H. Spes, K. Ackermann, F.Werner, E. Regar,
J. Rieber, P.Uberfuhr, H. Mudra. Mediziniache Wink, K/inikunr krnenatadt,
University of Munich, Germany
Determination of coronary flow reserve (CFR) is used toassessthefunctional
significance of transplant coronary artery disease (TxCAD). To evaluate the
potential influence of clinical factors and epicardial vascular morphology on
coronary flow reserve, 54 patients (age 48 + 12 years) were studied 30
& 37 months (range, 0.5-127 months) after othotopic heart transplant@ion
during annual surveillance angiography. Baseline and hyperemic coronary
flowaverage peak velooitywas meaauredtoeelculate CRF(16 wgadenosine,
0.014 in Doppler guide wire). In all patients (pts), intravascular ultrasound
(IVUS) was performed with a motorized pull-back eystem to determine mean
intimal index. Coronary angiograms were categorized visually as normal
or showing TxCAD (TxCAD +). Clinical factors analyzed were donor and
recipientage, time from transplantation, presence or absence of acute cellular
rejection (Rej +) and of left ventricular hypertrophy (LVH+).
By multivarfate regression analysis, only donor age (32 + 13 years, r =
-0.44, p < 0.01) and the presence of LVH (13/54 pts) were independently
correlated with CRF(LVH+, 2.4+0.7, vs. LVH-, 3.0+0.6, p <0.001). Neither
mean intimai index (20=k10Yo)northepresence (20/54pts)orabeence(34/54
pts) of angiographic TxCADpredictad CRF (TxCAD+, 2.9 +0.7 vs. TxCAD-,
2.9 +0.7, NS). An acute cellular rejection periode (grade 1A/B, ISHLT,20/54
pfe) did not influence CRF (Rej+, 2.7 + 0.7vs. Rej–, 2.9 + 0.7, NS).
Epicardial vaacular morphology as assessed by coronaty angiography
and IVUS does not correiate with the functional significance of TxCAD when
determined with intracoronary Doppler. However, higher donor ages and the
presence of LVH show an inverse relation to CRF.These findings have to be
considered when the hemodynamic significance of TxCAD is assessed by
means of coronary flow reserve measurements.
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1954-1351 FollOw-upReaults of The Multi-institutional Phase
I FDA Supervised Clinical Trials of Transcatheter
Occlusion of Atrial Septsl Defects With Buttoned
Devica
R. Zamora, P.S.Rae, T.R. Lloyd, R.H. Beekman Ill, E.B. Sideris. University
of Arfzona, Tucson,AZ’,USA
While safety, feasibility, and effectiveness of transeatheter occlusion of sa-
cundum atrial aeptal defect (ASD) with buttoned device (BD) have been
demonstrated, only short to medium term follow-up is known. This study
evaluated longer term follow-up results of the multi-institutional U.S. phase I
FDA supervised clinical trials of ASD closure by BD. Successful implantation
of BD was accomplished in 46/57 patients previously reported during a 19
month period ending in August 1992. This initial cohort was followed for 35
+ 13.3 months. Ages and weights at BD implantation, respectively, were 1 to
62 yrs (median 5) and 10 to 105 Kg. Follow-up included clinical evaluation,
chest x-ray, ECG and echo-Doppler etudies performed at 1, 6, and 12 mo.
after occlusion and yearly thereafter. At most recent follow-up 46/46 patients
(100%) had no or trivial residual shunt. The prevalence of residual shunts
declined from 85% at 1 month to 20% at last follow-up (p < 0.0001). Only one
patient (2%) had a moderate residual shunt 20 months after BD implantation,
this patient underwent placement of a second BO with only a trivial residual
shunt at 28 months of follow-up. No patient had clinical signs of ASD and
none required surgical intervention during the follow-up period. There were
no wire fractures on follow-up x-rays. ECG’Sshowed wandering ectopic atrial
pacemakers in 2 patients, and persistence of right ventricular hypertrophy
in one patient with no residual shunt noted by echo-Doppler. The previously
reported patient with asymptomatic atrial flutter, hae been off medication for
2 yeare without recurrence, There have been no cases of endocerditis or
thromboembolism in 138 patient-years of follow-up.
Conclusion: The BD provided effective closure of ASD in 46/46 patients
(100%) in whom BD was successfully implanted The prevalence and size of
reaidual shunts decreased during follow-up, and no instances of endocsrditis
or thromboembolism were observed.
-[ ASDandPFOClosura in Adultswith the Second
Generation ASDOS Device
H. Sievert, J. Dirks, S. Rux, U.U. Babic, P.Osypka, R. SchrAder,A. Fach,
D. Scherer. Cardiovascular Center Bethanien CCB, Frankfurt, Germany
Between 1.95 and 6.96, we attampted ASD (n = 22) or PFO (n = 6) closure
with the second generation double umbrella ASDOS device in 30 patients.
The age of the patients ranged between 20 and 74 years (mean 46 years).
The diameter of the ASD varied between 10 to 24 mm (mean 16 mm)
measured with transesophageal eohocardiography and from 10 to 27 mm
(mean 21) measured with a sizing balloon. QP:Qs in ASD patients ranged
from 1.6 to 3.6 with a mean of 2.2. The pulmonary artery pressure was
eleveted in 9 patients.
To close the defect completely, several repositioning maneuvers were
needed in the majority of patients. Implantation was primarily successful
(after the first or the eecond attempt) in 19/22 (66%) of the ASD patients and
in all PFO patients.
Cornp/icetions: Retroperitoneal bleeding (n = 1); pericardial hematoma,
drained per catheter (n = 2); umbrella arm fracture (n = 2). All patients were
doing well at follow-up.
Immediatelyaftertheclosure, residual shunting waa preaent in 11patients.
In 10 of these patients, the shunt was small. In one patient, it was moderate.
After 6 months, a residual shunt was present in 5/12 patients (42%). In
one of these patients, the shunt wae moderate as estimated by TEE. Qp:Qe
was <1.3 in ell patients.
Thus transcatheter ASD closure with the ASOOS device is clinically sue-
